In TOS there is a study called "Woodies Pivots" and it automatically paints the pivot you want (I use daily).$30,000 Millionaire said:
McInnis - are you painting the pivot and S/R lines yourself or have you found something to do it automatically?
In TOS there is a study called "Woodies Pivots" and it automatically paints the pivot you want (I use daily).$30,000 Millionaire said:
McInnis - are you painting the pivot and S/R lines yourself or have you found something to do it automatically?
bmoochie said:
If positive, what are you expectations of the stock once the markets react to it? I know we both and others probably have calls playing into it but you seem pretty plugged into this one for awhile now.
I'm going to give this a go. How are you putting in the volume profile? I need a view like this for tactical trades.McInnis 03 said:In TOS there is a study called "Woodies Pivots" and it automatically paints the pivot you want (I use daily).$30,000 Millionaire said:
McInnis - are you painting the pivot and S/R lines yourself or have you found something to do it automatically?
http://tos.mx/dLjrzho$30,000 Millionaire said:
McInnis - are you painting the pivot and S/R lines yourself or have you found something to do it automatically?
This is my hope as well. I'm in some August 20 calls that need some help right now, but on a more longer term basis I've seen how Alzheimer's can affect someone as it took my dad way too early. As someone who is fearful that I might need some help later in life due to possibly having the disease, any progress now gives me great hope for the future.Prognightmare said:
In February they announced results from their phase 2 trials that showed where participants regained cognitive and motor ability with zero side effects. It sent the stock from $20 to $117 in 3 days. If that has carried over into phase 3 then I can see a $100 move in the stock. Other treatments slow down the progression of the disease, their's actually reverses some of it.
My great grandmother died from Alzheimer's and I watched her become a zombie because her mind was gone long before her body gave out. Alzheimer's affects the living more than the victim. I choose to believe, I pray I'm right.
I ate there last night ironically.McInnis 03 said:
Chipotle can thank ME for their earnings.
How do you get the volume profile to come in from the left side?McInnis 03 said:
Have had a trade go my way today and thought I'd share what I was watching for and how I executed.....because now I'm left with some August monthly calls that are risk-free.
Anatomy of a trade: $BA - 2min chart shown
1) at the open, let things play out a bit, had my watchlist of 15 stocks open in order of percentage green to red, I watch for red's going green to find strength
2) started to see BA creep up from red, to barely red, went to 2min chart
3) Saw BA was against the daily pivot (purple line, I use "Woodies' daily pivots which calculate pivots with a heavier weight on recent price close)
4) Noticed BA broke daily pivot with authority (blue circle), at this point I'm willing to go long on a day scalp expecting to get to R1 so I bought 210c's at $2.38.
5) Rode these weeklies up to Resistance 1 (maroon line) where we pulled back to the opening range high (ORH), this doesn't worry me, this is where a lot of traders enter the play long on the pullback to ORH.
6) Continued to sell some of these calls as price continued to work it's way up, paying myself the whole way.
7) trading at 217 the 210c's were trading just above $7 so almost intrinsic value. At this point I can hold or find a way to sell out and up. I sold these 210c's for this week and bought 235c's for Aug 20 for really good credits.
8) Now my runners are Aug20 235c's at no-risk, if BA runs from here to then, we'll be just fine. If not, the trade is over anyways.
Notes:
If at bullet 3 BA reverses at the daily pivot, I don't play this trade.
If at bullet 5 BA re-enters the balance area deep I think about cutting the trade or lessening the risk significantly on a weekly play like this
On bullet 7, I simply wanted more time on this trade than 3 days.....and for the price of the options out that far, it made sense for me to take a credit and hold awhile. Letting the profits work for themselves.
Final Note:
I know everyone has an indicator or method they love.....I'm really getting into these Woodie's Pivots after ignoring them long ago.....Take a look at what happens to price at precisely R1 and again at R2. These poitns are where price reverses, almost to the penny. Now also realize these pivots are drawn at the bell of the open......so now you see where the strength of these comes into play. I'm having great success using them as strength/resistance lines and when/where to trim/add. Just another indicator to think about that isn't necessarily a laggard.
NVM, got it. Is the volume profile supposed to repeat on each day on the scale?AG 2000' said:How do you get the volume profile to come in from the left side?McInnis 03 said:
Have had a trade go my way today and thought I'd share what I was watching for and how I executed.....because now I'm left with some August monthly calls that are risk-free.
Anatomy of a trade: $BA - 2min chart shown
1) at the open, let things play out a bit, had my watchlist of 15 stocks open in order of percentage green to red, I watch for red's going green to find strength
2) started to see BA creep up from red, to barely red, went to 2min chart
3) Saw BA was against the daily pivot (purple line, I use "Woodies' daily pivots which calculate pivots with a heavier weight on recent price close)
4) Noticed BA broke daily pivot with authority (blue circle), at this point I'm willing to go long on a day scalp expecting to get to R1 so I bought 210c's at $2.38.
5) Rode these weeklies up to Resistance 1 (maroon line) where we pulled back to the opening range high (ORH), this doesn't worry me, this is where a lot of traders enter the play long on the pullback to ORH.
6) Continued to sell some of these calls as price continued to work it's way up, paying myself the whole way.
7) trading at 217 the 210c's were trading just above $7 so almost intrinsic value. At this point I can hold or find a way to sell out and up. I sold these 210c's for this week and bought 235c's for Aug 20 for really good credits.
8) Now my runners are Aug20 235c's at no-risk, if BA runs from here to then, we'll be just fine. If not, the trade is over anyways.
Notes:
If at bullet 3 BA reverses at the daily pivot, I don't play this trade.
If at bullet 5 BA re-enters the balance area deep I think about cutting the trade or lessening the risk significantly on a weekly play like this
On bullet 7, I simply wanted more time on this trade than 3 days.....and for the price of the options out that far, it made sense for me to take a credit and hold awhile. Letting the profits work for themselves.
Final Note:
I know everyone has an indicator or method they love.....I'm really getting into these Woodie's Pivots after ignoring them long ago.....Take a look at what happens to price at precisely R1 and again at R2. These poitns are where price reverses, almost to the penny. Now also realize these pivots are drawn at the bell of the open......so now you see where the strength of these comes into play. I'm having great success using them as strength/resistance lines and when/where to trim/add. Just another indicator to think about that isn't necessarily a laggard.
McInnis 03 said:
Chipotle can thank ME for their earnings.
Shepherd's Pie burrito?59 South said:McInnis 03 said:
Chipotle can thank ME for their earnings.
New one just opened a short walk from me earlier this summer. It's catching on quick already.
Here are my VolPro settings and yes, I get a new one each day.AG 2000' said:NVM, got it. Is the volume profile supposed to repeat on each day on the scale?AG 2000' said:How do you get the volume profile to come in from the left side?McInnis 03 said:
Have had a trade go my way today and thought I'd share what I was watching for and how I executed.....because now I'm left with some August monthly calls that are risk-free.
Anatomy of a trade: $BA - 2min chart shown
1) at the open, let things play out a bit, had my watchlist of 15 stocks open in order of percentage green to red, I watch for red's going green to find strength
2) started to see BA creep up from red, to barely red, went to 2min chart
3) Saw BA was against the daily pivot (purple line, I use "Woodies' daily pivots which calculate pivots with a heavier weight on recent price close)
4) Noticed BA broke daily pivot with authority (blue circle), at this point I'm willing to go long on a day scalp expecting to get to R1 so I bought 210c's at $2.38.
5) Rode these weeklies up to Resistance 1 (maroon line) where we pulled back to the opening range high (ORH), this doesn't worry me, this is where a lot of traders enter the play long on the pullback to ORH.
6) Continued to sell some of these calls as price continued to work it's way up, paying myself the whole way.
7) trading at 217 the 210c's were trading just above $7 so almost intrinsic value. At this point I can hold or find a way to sell out and up. I sold these 210c's for this week and bought 235c's for Aug 20 for really good credits.
8) Now my runners are Aug20 235c's at no-risk, if BA runs from here to then, we'll be just fine. If not, the trade is over anyways.
Notes:
If at bullet 3 BA reverses at the daily pivot, I don't play this trade.
If at bullet 5 BA re-enters the balance area deep I think about cutting the trade or lessening the risk significantly on a weekly play like this
On bullet 7, I simply wanted more time on this trade than 3 days.....and for the price of the options out that far, it made sense for me to take a credit and hold awhile. Letting the profits work for themselves.
Final Note:
I know everyone has an indicator or method they love.....I'm really getting into these Woodie's Pivots after ignoring them long ago.....Take a look at what happens to price at precisely R1 and again at R2. These poitns are where price reverses, almost to the penny. Now also realize these pivots are drawn at the bell of the open......so now you see where the strength of these comes into play. I'm having great success using them as strength/resistance lines and when/where to trim/add. Just another indicator to think about that isn't necessarily a laggard.
If they haven't started the phase 3 trials, don't expect an update this weekend. Hopefully, someone else can find something more substantive. I still believe in stock but I know some of you are in calls, I own shares. Plan your risk accordingly if you have calls because they expire. Everyone is expecting them to say something this weekend so a runup into Friday will probably occur. I just don't want anyone here getting caught bag holding calls should SAVA not say anything.Quote:
Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help conduct the Phase 3 clinical program of simufilam for Alzheimer's disease. Consistent with previous guidance, Cassava Sciences plans to initiate this Phase 3 program in the second half of 2021.
"Having completed over 250 clinical studies in neuroscience, we believe Premier Research International understands how to conduct clinical studies in patients with Alzheimer's disease," said Remi Barbier, President & CEO of Cassava Sciences. "With Premier Research as our CRO partner, we now look forward to advance simufilam into Phase 3 clinical testing."
"Premier Research is pleased to be Cassava Sciences' CRO of choice for this pivotal program," said Krista Armstrong, Senior Vice President, Clinical Development Services and Global Head of Neuroscience, Premier Research. "Premier Research has deep experience in conducting complex studies in neuroscience. We look forward to bringing our extensive knowledge and experience in Alzheimer's disease to Cassava Sciences' pivotal Phase 3 program of simufilam."
About Premier Research
Premier Research, a clinical research and development company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. For more information, please visit https://premier-research.com
Just to add on to this -Prognightmare said:
Ok gang, a friend of mine pointed out that SAVA may not even be in phase 3 trials. I did some searching and here's what I've found.If they haven't started the phase 3 trials, don't expect an update this weekend. Hopefully, someone else can find something more substantive. I still believe in stock but I know some of you are in calls, I own shares. Plan your risk accordingly if you have calls because they expire. Everyone is expecting them to say something this weekend so a runup into Friday will probably occur. I just don't want anyone here getting caught bag holding calls should SAVA not say anything.Quote:
Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help conduct the Phase 3 clinical program of simufilam for Alzheimer's disease. Consistent with previous guidance, Cassava Sciences plans to initiate this Phase 3 program in the second half of 2021.
"Having completed over 250 clinical studies in neuroscience, we believe Premier Research International understands how to conduct clinical studies in patients with Alzheimer's disease," said Remi Barbier, President & CEO of Cassava Sciences. "With Premier Research as our CRO partner, we now look forward to advance simufilam into Phase 3 clinical testing."
"Premier Research is pleased to be Cassava Sciences' CRO of choice for this pivotal program," said Krista Armstrong, Senior Vice President, Clinical Development Services and Global Head of Neuroscience, Premier Research. "Premier Research has deep experience in conducting complex studies in neuroscience. We look forward to bringing our extensive knowledge and experience in Alzheimer's disease to Cassava Sciences' pivotal Phase 3 program of simufilam."
About Premier Research
Premier Research, a clinical research and development company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. For more information, please visit https://premier-research.com
AG 2000' said:Just to add on to this -Prognightmare said:
Ok gang, a friend of mine pointed out that SAVA may not even be in phase 3 trials. I did some searching and here's what I've found.If they haven't started the phase 3 trials, don't expect an update this weekend. Hopefully, someone else can find something more substantive. I still believe in stock but I know some of you are in calls, I own shares. Plan your risk accordingly if you have calls because they expire. Everyone is expecting them to say something this weekend so a runup into Friday will probably occur. I just don't want anyone here getting caught bag holding calls should SAVA not say anything.Quote:
Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help conduct the Phase 3 clinical program of simufilam for Alzheimer's disease. Consistent with previous guidance, Cassava Sciences plans to initiate this Phase 3 program in the second half of 2021.
"Having completed over 250 clinical studies in neuroscience, we believe Premier Research International understands how to conduct clinical studies in patients with Alzheimer's disease," said Remi Barbier, President & CEO of Cassava Sciences. "With Premier Research as our CRO partner, we now look forward to advance simufilam into Phase 3 clinical testing."
"Premier Research is pleased to be Cassava Sciences' CRO of choice for this pivotal program," said Krista Armstrong, Senior Vice President, Clinical Development Services and Global Head of Neuroscience, Premier Research. "Premier Research has deep experience in conducting complex studies in neuroscience. We look forward to bringing our extensive knowledge and experience in Alzheimer's disease to Cassava Sciences' pivotal Phase 3 program of simufilam."
About Premier Research
Premier Research, a clinical research and development company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. For more information, please visit https://premier-research.com
You are correct in that they haven't started phase 3 yet.
The catalyst coming is next week is the Alzheimer's Association International Conference, running Monday through Friday next week. I saw somewhere online that next Thursday they are supposed to present an update with nine months of data on the trial currently under way.
I've got an inquiry in with investor relations to confirm when they'll present.
Keep us posted on that inquiry. Would be great to know the day they're presenting. I've been assuming it will be the 29th (last day of conference).AG 2000' said:Just to add on to this -Prognightmare said:
Ok gang, a friend of mine pointed out that SAVA may not even be in phase 3 trials. I did some searching and here's what I've found.If they haven't started the phase 3 trials, don't expect an update this weekend. Hopefully, someone else can find something more substantive. I still believe in stock but I know some of you are in calls, I own shares. Plan your risk accordingly if you have calls because they expire. Everyone is expecting them to say something this weekend so a runup into Friday will probably occur. I just don't want anyone here getting caught bag holding calls should SAVA not say anything.Quote:
Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help conduct the Phase 3 clinical program of simufilam for Alzheimer's disease. Consistent with previous guidance, Cassava Sciences plans to initiate this Phase 3 program in the second half of 2021.
"Having completed over 250 clinical studies in neuroscience, we believe Premier Research International understands how to conduct clinical studies in patients with Alzheimer's disease," said Remi Barbier, President & CEO of Cassava Sciences. "With Premier Research as our CRO partner, we now look forward to advance simufilam into Phase 3 clinical testing."
"Premier Research is pleased to be Cassava Sciences' CRO of choice for this pivotal program," said Krista Armstrong, Senior Vice President, Clinical Development Services and Global Head of Neuroscience, Premier Research. "Premier Research has deep experience in conducting complex studies in neuroscience. We look forward to bringing our extensive knowledge and experience in Alzheimer's disease to Cassava Sciences' pivotal Phase 3 program of simufilam."
About Premier Research
Premier Research, a clinical research and development company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. For more information, please visit https://premier-research.com
You are correct in that they haven't started phase 3 yet.
The catalyst coming is next week is the Alzheimer's Association International Conference, running Monday through Friday next week. I saw somewhere online that next Thursday they are supposed to present an update with nine months of data on the trial currently under way.
I've got an inquiry in with investor relations to confirm when they'll present.
sameAG 2000' said:
I just got a notification for a Form 4 for $SAVA, Remi exercising option for 2800 shares.
Spreads make it more palatable. But yeah it's definitely YOLO pricing, has been since their phase 2 data came out.RenoAg said:
Just looked. These SAVA options ain't for small bit playas. Yipes.
AG 2000' said:Spreads make it more palatable. But yeah it's definitely YOLO pricing, has been since their phase 2 data came out.RenoAg said:
Just looked. These SAVA options ain't for small bit playas. Yipes.
For example, August 120/135 spread was $2.50 this morning.
Heck, you can go out and get the 160s for under $4 still. It's going to be well over that if they present good news next week.
No they are not, they're overly juiced.RenoAg said:
Just looked. These SAVA options ain't for small bit playas. Yipes.
You buy a call at the lower price, sell one at the upper price (as a single transaction).RenoAg said:AG 2000' said:Spreads make it more palatable. But yeah it's definitely YOLO pricing, has been since their phase 2 data came out.RenoAg said:
Just looked. These SAVA options ain't for small bit playas. Yipes.
For example, August 120/135 spread was $2.50 this morning.
Heck, you can go out and get the 160s for under $4 still. It's going to be well over that if they present good news next week.
Relative newbie here. Need to educate myself on these . spreads. Sounds debaucherous. Maybe hoorish even. I'm intrigued.
The August ones have been overly juiced for a while. I was told not to sell calls into these a while back (I think by ag2000) b/c of the conference. Although without the pullback I would have lost my shares last week. Been a crazy run-up so far. Feels good not to have to stress it going on a tear now, but still not sure if I won't sell some calls.Prognightmare said:No they are not, they're overly juiced.RenoAg said:
Just looked. These SAVA options ain't for small bit playas. Yipes.
FJ43 said:
Sorry guys so quiet and not helping provide some plays.
My mom had emergency surgery yesterday then during that found her heart was weak. So I have been out of it mentally to execute and making lots of mistakes trading emotionally vs technically.
Don't want to lead you guys down the same path today.
May go flat and head for TX but waiting to hear test results.